Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities

IFN-  Skews Monocytes into CD56+-Expressing Dendritic Cells with Potent Functional Activities In Vitro and In Vivo

(2014) C. Papewalis et al.   JOURNAL OF IMMUNOLOGY

Abstract 5423: New diazonamide analogs demonstrate remarkably larger therapeutic window compared to taxanes and vinca alkaloids in rodents

(2012) Lin Li et al.   CANCER RESEARCH

Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells

(2012) Barbara Drobits et al.   JOURNAL OF CLINICAL INVESTIGATION

TRAIL+ Human Plasmacytoid Dendritic Cells Kill Tumor Cells In Vitro: Mechanisms of Imiquimod- and IFN- -Mediated Antitumor Reactivity

(2012) M. L. Kalb et al.   JOURNAL OF IMMUNOLOGY

DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by    T lymphocytes

(2011) O. Nussbaumer et al.   BLOOD

The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues

(2011) Jurjen Tel et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Type I interferon is selectively required by dendritic cells for immune rejection of tumors

(2011) Mark S. Diamond et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses

(2011) I. Jolanda M. de Vries et al.   MOLECULAR IMMUNOLOGY

Poly(I:C) Enhances the Susceptibility of Leukemic Cells to NK Cell Cytotoxicity and Phagocytosis by DC

(2011) Eva Lion et al.   PLoS One

Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

(2010) Gerty Schreibelt et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

IL-2 Costimulation Enables Statin-Mediated Activation of Human NK Cells, Preferentially through a Mechanism Involving CD56+ Dendritic Cells

(2010) G. Gruenbacher et al.   CANCER RESEARCH

Type I interferon: friend or foe?

(2010) Giorgio Trinchieri   JOURNAL OF EXPERIMENTAL MEDICINE

Human plasmacytoid dendritic cells are unresponsive to bacterial stimulation and require a novel type of cooperation with myeloid dendritic cells for maturation

(2009) D. Piccioli et al.   BLOOD

Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion

(2009) B. Jahrsdorfer et al.   BLOOD

CD56+ human blood dendritic cells effectively promote TH1-type    T-cell responses

(2009) G. Gruenbacher et al.   BLOOD

Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients

(2009) G. Stary et al.   BLOOD

In situ Expression of Tumor Antigens by Messenger RNA-Electroporated Dendritic Cells in Lymph Nodes of Melanoma Patients

(2009) D. H. Schuurhuis et al.   CANCER RESEARCH

Physiological Role of Plasmacytoid Dendritic Cells and Their Potential Use in Cancer Immunity

(2009) Jorge Schettini et al.   Clinical & Developmental Immunology

CD2 Distinguishes Two Subsets of Human Plasmacytoid Dendritic Cells with Distinct Phenotype and Functions

(2009) T. Matsui et al.   JOURNAL OF IMMUNOLOGY

Plasmacytoid dendritic cells in the skin: To sense or not to sense nucleic acids

(2009) Curdin Conrad et al.   SEMINARS IN IMMUNOLOGY

Killer dendritic cells: IKDC and the others

(2008) Mathieu Bonmort et al.   CURRENT OPINION IN IMMUNOLOGY